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The clinical course ofa young woman followingtwo separate suicide attempts using the herbicide paraquat
is reported. The patient survived an intramuscular injection of paraquat almost asymptomatically, but later
exhibited a typical fatal course with fulminant proliferative pulmonary fibrosis after an intravenous injection.
Fibrosis and death occurred despite a therapeutic regimen based upon a known action of paraquat, the
generation of superoxide (02.-), using superoxide dismutase, a-tocopherol, and ascorbic acid in conjunction
with forced diuresis and prednisone. While treatment failed explanations for the failure oftherapy in this case
and current therapeutic alternatives are discussed so that they may be considered when future cases are
encountered.
Paraquat (methyl viologen, 1, 1'- dimethyl-4,4'-dipyridylium dichloride) is a herbi-
cide which has been responsible for 564 deaths reported to the manufacturer since its
introduction in 1958. An estimated 60% of these fatalities were successful suicides.
An episode oftransient pulmonary edema with kidney and liver dysfunction are often
the first symptoms, but they do not ordinarily appear until a day or more after
paraquat ingestion. Death usually occurs after one or more weeks and most often is
the result of a relentless, fulminant pulmonary fibrosis which is not clinically signifi-
cant for the first week or longer.
The precise mechanism of the tissue damage produced by paraquat is unknown,
but the evidence implicates the reduction products of oxygen as shown in Fig. 1. By
accepting electrons from NADPH, cytochrome c reductase [1] and possibly glutath-
ione reductase [2], among others, paraquat can act as an oxidation-reduction couple.
Reduced paraquat very rapidly reduces molecular oxygen to its toxic free radical,
superoxide (02..) (Fig. IA) [3]. Superoxide may produce tissue injury by reacting
directly with cellular components or by generating other very reactive species of
oxygen such as hydroxyl radical (OH-) and singlet oxygen (102) by the Haber-Weiss
reaction [4] (Fig. 1B). Beyond the peroxidation oflipids, and perhaps thiol oxidation,
the particular consequences of these species of oxygen in tissues are not well de-
scribed. The mechanism of toxicity of any of these species of oxygen is not known.
While gastrointestinal absorption may be prevented by the administration of
bentonite or Fuller's earth [5], no method exists to limit paraquat absorption from
parenteral sites. Tissue binding is rapid and lung even concentrates the compound
[6]. Dialysis has not been particularly effective and has shown no advantage over
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FIG. 1. Generation oftoxic species ot oxygen with paraquat. A shows a possible pathway ofelectron flow from reduced
pyridine nucleotide (NADPH) to superoxide(02.). B is the Haber-Weiss reaction generating hydroxyl radical(OH.)and
singlet oxygen(102)II. superoxide dismutase (SOD). hydrogen peroxide(H202).hydroxide (OH-).
forced diuresis [7]. Once paraquat is bound to tissues, therefore, major therapeutic
efforts must be devised and directed toward the prevention of tissue injury and the
ultimate fibrosis.
We report the results of therapy in a case of paraquat poisoning after two suicide
attempts, first by intramuscular then by intravenous injection of the compound. The
treatment regimen used was designed to interfere with the consequence ofsuperoxide
(02.-) production by paraquat. While some data concerning the efficiency of similar
regimens exist in experimental animals, no published information is available for
man.
REPORT OF A CASE
Following the intramuscular injection ofabout 60 mg ofa commercial preparation
of the herbicide paraquat into her anterior thighs, a 24-year-old woman was referred
for treatment to the Hospital of the University of Pennsylvania. She had attempted
suicide many times before, both by self-mutilation and by a variety of drug inges-
tions. Her history also included frequent episodes of severe asthma, gastrointestinal
bleeding from stress ulcers, obesity, schizophrenia, and recent deep vein thrombosis
with a documented pulmonary embolus four years previously.
Upon admission the patient complained of abdominal discomfort and had a fever
of 102.00 F. Her physical examination and laboratory tests were unremarkable except
for blood gases which were consistent with her chronic asthma (pH 7.47, PO2 89
mmHg, pCO2 32 mmHg and HCO323 meq/ 1). During this hospitalization a painful
erythematous area 4-5 cm in diameter appeared at the injection sites. She developed
leukocytosis 20,000 per mm3 by the fourth hospital day and a low grade fever. No
microorganisms were cultured from the urine, cerebrospinal fluid, or blood; her chest
x-ray was unremarkable.
Treatment included forced diuresis (680-5075 ml urine output per day) to promote
paraquat excretion and ascorbic acid 6.0 grams per day to provide a source of
reducing equivalents to allay the oxidizing effect of paraquat. Oral dicloxicillin and
probenicid were given to treat a possible staphyloccal cellulitis at the injection site.
She returned to the referring hospital on the sixth hospital day and continued to
recover uneventfully.
Thirty days after the first paraquat injection the patient procured a commercial
paraquat preparation, and injected 2 ml intravenously (550-600 mg). Upon confess-
ing her suicide attempt the next morning she was transferred to the medical service
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where therapy was started with a forced diuresis (4000-8000 ml perday) and ascorbic
acid, 1 gm four times daily. She complained of episgastic cramping with nausea and
vomiting.
Physical examination revealed an occasional respiratory wheeze, moderate ankle
edema, and erythematous areas at the sites of the previous paraquat injections.
Sixteen hours after injection paraquat was not detectable in serum but was found in
the urine. By day 3 she was excreting 4 mg of paraquat per day (Table 1). By the
fourth hospital day she developed signs ofhepatic and renal toxicity. The creatinine
rose to a value of 3.7 mg% on the seventh hospital day, then returned to 0.9 to 1.1
mg% over the next several days. She complained of right upper quadrant pain; the
serum lactic dehydrogenase rose to 1300 IU/l serum analine tranasaminase (SGOT)
level to 92 IU/1 and serum asparate transaminase (SGPT) level.to 94 IU/1. Bilirubin
and prothrombin time remained normal. The patient developed fever (100.000) and
leukocytosis (20,500) per mm3 on the seventh day without definitive proofofbacterial
infection until late in the hospital course.
Ninety hours after the paraquat injection, therapy specifically directed against the
consequence of superoxide radical generation was begun. A supply of the enzyme
superoxide dismutase was obtained first as the bovine enzyme (Palosein, Diagnostic
Data, Inc., Mountain View, California), then as the human enzyme (Ontosein,
Worthington Biochemical Corporation, Freehold, N.J.). After obtaining informed
consent it was administered at a dose of 5 mg every three hours intramuscularly.
Ascorbic acid was raised to 8 gm per day in divided doses and 544 IUa-tocopherol
was given intramuscularly twice daily in an attempt to inhibit membrane lipid
oxidation. Finally, 20 mg methyl prednisone was given four times daily in an attempt
to retard the inflammatory reaction and its potential contribution to the expected
pulmonary fibrosis.
Despite this therapy her pulmonary status continued to deteriorate and she was
transferred 18 hrs later to the Medical Intensive Care Unit with a P02 of 31 mmHg,
pH of 7.35, pCO2 of 32 mmHg, and HCO3 of 15.2 meq/I. A chest x-ray showed a
diffuse bilateral interstitial process consistent with edema. Pulmonary arterial pres-
sure was measured at 45/30 mmHg with a wedge pressure of 5-7 cm. She responded
to intubation, 100% 02, and a positive end expiratory pressure (PEEP) of 5 cm by
raising her P02 to 66 mmHg. Over the ensuing seven days her fractional inspired
oxygen (FI02) and PEEP were gradually reduced from 50% and 15 cm to 30%and 0
cm respectively, in order to administer only enough O2 to maintain adequate peri-
pheral oxygenation, without accelerating the pulmonarytoxicity ofparaquat. Accor-
dingly she was maintained relatively hypoxic (pO2 35-80 mmHg). She also received
digoxin, furosemide and theophylline to control volume overload from the forced
diuresis, and bronchoconstriction. Ampicillin was given for a possible E. coli pneu-
monia. Urinary excretion of paraquat rose progressively (Table 1) reaching a peak
value of 22 mgm/24 hr period two days before death. Pulmonary deterioration
continued however and on the 20th hospital day she expired, unable to maintain her
P02 above 30 mmHg, despite 100% HO2 and 20 cmPEEP.
At autopsy the lungs were diffusely involved with a pneumonic process with the
most dependent portions of the lower lobes less affected. The alveolar spaces were
obliterated by florid fibrosis, characterized by proliferation of fibroblasts with loose,
light stained collagen. No hyaline membranes were present. The capillaries were
patent with the endothelial cell lining preserved. The bronchiolar and alveolar ducts
were dilated, and many were filled with red cells as well as numerous hemosiderin-
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TABLE 1
Urinary Levels of Paraquat
Hospital Day Concentration Daily Output
(mg/l) (mg/24 hr)
3 1.3 4
6 2.8 16
12 1.0 14
18 1.4 22
Estimated total excretion 280 mg
aAssayed by reduction with dithionite at 400 nm [23] on 24 hr urine specimens collected on the hospital days noted.
laden macrophages. A mononuclear cell infiltrate was noted. Histologically the
pulmonary vasculature was normal (Figs. 2 and 3). No significant abnormalities were
seen in the remaining organs.
Tissue levels of paraquat found at autopsy are indicated in Table 2.
DISCUSSION
This patient recovered completely from an intramuscular injection of paraquat
only to succumb to a much larger intravenous dose, despite intensive therapeutic
efforts. The nearly asymptomatic response to the intramuscular dose is not surprising
since muscle binds paraquat, and tissue levels decrease much more slowly in muscle
than elsewhere [8,9]. The intravenous dose, however, exhibited the typical course in
paraquat poisoning and was not, therefore, apparently influenced by the previous
exposure.
The usual clinical course following a fatal dose ofparaquat is reflected in this case.
Immediately after taking the poison, nausea and vomiting are the only significant
symptoms. A few days later, multisystem toxicity with pulmonary edema, kidney
failure, and liver dysfunction follow, all of which improve after afew days to a week.
Although an occasional patient recovers completely [7,10], most develop pulmonary
distress, become hypoxic, require oxygen therapy, and soon die with fulminant
irreversible pulmonary fibrosis. The histological picture seen in sections of the
patient's lung is typical of that observed in other fatal cases.
Since nausea and vomiting are found in parenteral as well as oral poisonings [7,11],
these symptoms are produced by more than the very high concentrations which are in
contact with the gastric mucosa after ingestion. Leucocytosis and fever were also seen
after both parenteral doses in this case and have been commonly found in previous
oral cases [11,12]. The mechanism of these reactions remains unexplained although
tissue necrosis may play a role.
Throughout this patient's hospital course she excreted significant quantities of
paraquat, a total of approximately 280 mg (Table 1). This high urine output of
paraquat would be expected to reflect large tissue stores; however, this was not the
case among the tissues assayed (Table 2). From the tissue levels the maximal body
burden at death would be much less than 3.0 mg. This data would seem to contradict
the urinary levels. To be consistent, either the tissue stores of paraquat must have
been exhausted just previous to death, or paraquat must have been sequestered in a
tissue which was not available for analysis such as muscle, liver; or skin. Since
paraquat excretion is usually biphasic with large quantities excreted within the first
twenty-four hours, recovery of an estimated 265 mg of paraquat after the first day is
roughly consistent with a total body burden of 550-600 mg paraquat, the amount
originally injected intravenously.
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FIG. 2. Diffuse intraalveolar fibrosis (Trichrome lOX).
Therapy in this case was based upon the hypothesis that the generation ofsuperox-
ide, a known action of paraquat, was also its toxic action, especially in lung. This
hypothesis is supported by the dependence of paraquat toxicity on inspired oxygen
concentrations [13,14], the finding that superoxide dismutase has a protective effect
in paraquat poisoned rats [15], and the similarity of the pulmonary histologic
changes seen in oxygen poisoning to those in paraquat poisoning [4]. Superoxide
dismutase was given to supplement endogenous superoxide dismutase in order to
prevent superoxide from reacting in ways harmful to the cell. Although toxicity
studies are not complete, the enzyme has no presently known toxicity [16]. a -
tocopherol is a lipid phase antioxidant which protects against lipid peroxidation, a
potential consequence of superoxide [4]. In paraquat poisoned rats lipid peroxida-
tion is increased and paraquat is much more toxic in a-tocopherol deficient rats [1].
Ascorbic acid was used to provide aqueous phase reducing equivalents in both the
intracellular and extracellular fluid spaces. No reports of the use of such a treatment
regimen in man have been published.
There are a number ofpossible reasons for the failure ofthe treatment approach in
this case. First, the specific therapy was not started until nearly four days after the
injection. Certainly by this time extensive, possibly irreversible, damage had oc-
curred. Second, there is no information available on the appropriate dosages ofthese
compounds to use in paraquat poisoning or other analogous situations. However the
Michealis constant ofsuperoxide dismutase [18]is, most certainly, much greater than
the concentration of superoxide. Thus, even in the presence of paraquat additional
enzyme might not have a significant effect; nevertheless a protective effect of the
enzyme in paraquat poisoned rats has been observed [15]. Third, it has been shown
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FIG. 3. Alveolar spaces have been obliterated by proliferating fibroblasts with elongated basophilic cytoplasm, large
vesicular irregular nuclei, and loose interstitial collagen. Capillaries are patent with preserved endothelial lining (Tri-
chrome IOOX).
recently that the lung actively concentrates paraquat [6]. Since administered superox-
ide dismutase presumably remains in the extracellular space, it may not effectively
protect intracellular sites ofparaquat action. Fourth, oxygen therapy was required to
maintain peripheral otygenation. Since increasing the fractional oxygen content of
inspired air aggravates paraquat injury of lung [13], oxygen therapy, although
necessary to maintain life, may have resulted in much more extensive paraquat
mediated lung injury. Fifth, it is possible that superoxide is not directly involved in
paraquat toxicity in man. Data from studies with E. coli suggest mechanisms other
than superoxide may be responsible for injury in these organisms [19]. This may
represent a second unrelated toxic action of these compounds which is not amenable
to treatment directed at dissipation of the superoxide anion.
In future cases of paraquat poisoning other therapeutic possibilities should also be
considered. Hemoperfusion, over activated charcoal or a cation exchange resin has
reduced serum paraquat concentrations in experimental animals [20]. Paraquat is
inactivated by bentonite or Fuller's earth; and gastric lavage and passage of these
agents can be a life-saving measure in some cases. Experimental animals have been
protected from an otherwise lethal dose with administration of bentonite as long as
ten hours after paraquat ingestion [21]. They may also be beneficial when paraquat is
taken by other routes. Steroids and cytotoxic agents have been used without marked
success [7]; however, a recovery from the proliferative pulmonary fibrosis of para-
quat poisoning as well as two therapeutic failures have been recently reported with
azathioprine and potassium amino benzoate [10,22,23].
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TABLE 2
Tissue Levels of Paraquat
Tissue Paraquat Concentration
(ugm/gmn)
Spleen 0.01
Vertebral column 0.03
Kidney 0.02
Brain 0.02
aParaquat was not detected in lung (<0.01 ,Igm/gm), fat, heart, cervix, ovaries, thyroid, urinary bladder, orstomach.
Currently no therapy for paraquat poisoning is uniformily successful and almost
all repeated cases have resulted in a fatal outcome even after ingestion of relatively
small amounts ofthe compound [24]. Ideal treatment would inhibit the proliferative
pulmonary fibrosis while permitting the recovery ofother pulmonary cell types. Until
such a therapy is described we are left with absorption, diuresis, or dialysis of
paraquat in an effort to recover the compound before irreversible damage is done. To
judge whether antioxidants such as those employed in the present case can be of
benefit in paraquat poisoning must await a larger sample of reported cases. Further-
more, to enhance any opportunity for success they should be administered as
promptly as possible after poisoning occurs to possibly prevent irreversible damage.
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